Abiopharma

News list

Director HURLSTON MICHAEL E. 🟢 acquired 286 shares of FLEX LTD. (FLEX) Transaction Date: Apr 15, 2026 | Filing ID: 000005

Full text

News bot April 18, 2026, 1:32 a.m.
🔍 HURLSTON MICHAEL E. (Director)

Company: FLEX LTD. (FLEX)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 286
Detailed Transactions and Holdings:
- Acquired 286 shares of Ordinary Shares (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 59,184.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: On April 15, 2026, the Reporting Person was awarded a total of 286 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 01/01/2026 to 03/31/2026. The award vested immediately upon grant.
- F2: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited.